Unknown

Dataset Information

0

Galectin-8N-Selective 4-Halophenylphthalazinone-Galactals Double π-Stack in a Unique Pocket.


ABSTRACT: Galectin-8 contains two different carbohydrate recognition domains (CRDs). Selective inhibitors for at least one CRD are desirable for galectin-8 biology studies and potentially for pharmacological purposes. Structure-guided design led to the discovery of potent and selective glycomimetic-heterocycle hybrid ligands, with a 4-(p-bromophenyl)phthalazinone derivative displaying a 34 μM K d for galectin-8N (N-terminal CRD), no binding to galectin-8C (C-terminal CRD), -1, -3, -4N, -7, -9C, or -9N, and >40-fold selectivity over galectin-4C. Selectivity was achieved with the halogenated 4-phenylphthalazinone moiety occupying a galectin-8N-specific sub-pocket. A 1.30 Å resolution X-ray structure revealed the phthalazinone moiety stacking with Arg45 and the 4-bromophenyl moiety stacking both Arg59 and Tyr141 of galectin-8N. Physicochemical and in vitro ADME studies revealed a desirable LogD, which also translated to good passive permeability. The chemical, microsome, and plasma stability support these compounds as promising tool compounds and candidates for hit-to-lead optimization.

SUBMITTER: van Klaveren S 

PROVIDER: S-EPMC11318003 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Galectin-8N-Selective 4-Halophenylphthalazinone-Galactals Double π-Stack in a Unique Pocket.

van Klaveren Sjors S   Hassan Mujtaba M   Håkansson Maria M   Johnsson Richard E RE   Larsson Jessica J   Jakopin Žiga Ž   Anderluh Marko M   Leffler Hakon H   Tomašič Tihomir T   Nilsson Ulf J UJ  

ACS medicinal chemistry letters 20240722 8


Galectin-8 contains two different carbohydrate recognition domains (CRDs). Selective inhibitors for at least one CRD are desirable for galectin-8 biology studies and potentially for pharmacological purposes. Structure-guided design led to the discovery of potent and selective glycomimetic-heterocycle hybrid ligands, with a 4-(<i>p</i>-bromophenyl)phthalazinone derivative displaying a 34 μM <i>K</i> <sub>d</sub> for galectin-8N (N-terminal CRD), no binding to galectin-8C (C-terminal CRD), -1, -3,  ...[more]

Similar Datasets

| S-EPMC3674282 | biostudies-literature
| S-EPMC10692381 | biostudies-literature
| S-EPMC4613944 | biostudies-literature
| S-EPMC5430388 | biostudies-literature
| S-EPMC11350569 | biostudies-literature
2014-10-03 | GSE60823 | GEO
| S-EPMC5429621 | biostudies-literature
| S-EPMC10457557 | biostudies-literature
2014-10-03 | E-GEOD-60823 | biostudies-arrayexpress
| S-EPMC8975908 | biostudies-literature